16 molecular lab workers in Tuguegarao have COVID-19 | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

16 molecular lab workers in Tuguegarao have COVID-19

By: - Correspondent /
/ 04:16 PM January 14, 2022

TUGUEGARAO CITY––The molecular laboratory of the Cagayan Valley Medical Center (CVMC) in Barangay Carig Sur in this city was closed for disinfection Friday, Jan. 14, after 16 of its workers tested positive for COVID-19.

Dr. Glenn Mathew Baggao, CVMC chief, said the virus-infected workers were quarantined.

Baggao said the uninfected staff members of the laboratory would resume swabbing and sample collection on Saturday.

Article continues after this advertisement

The facility was opened in August last year to help speed up COVID-19 testing in the region, processing an average of 300 to 400 specimens daily.

FEATURED STORIES

Specimen referrals were sent to other molecular laboratories, including the Department of Health laboratory in the region.

Baggao said 59 medical workers at the CVMC had also contracted the viral disease, but most of them did not show symptoms. INQ

Article continues after this advertisement

lzb

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

www
www
business
globalnation
entertainment
TAGS: COVID-19, CVMC, disinfection, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.